1,025
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Case report: nanopore targeted sequencing in the diagnosis of invasive pulmonary Aspergillus infection in a patient with acute promyelocytic leukemia

, , &
Article: 2225345 | Received 28 Dec 2021, Accepted 18 Dec 2022, Published online: 03 Aug 2023

References

  • Patterson TF, Thompson III GR, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016 Aug 15;63(4):e1–e60. doi:10.1093/cid/ciw326
  • Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol. 2011 Apr;49(Suppl 1):S7–S12. doi:10.3109/13693786.2010.505204
  • Vandewoude K, Blot S, Benoit D, et al. Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. Acta Clin Belg. 2004 Sep-Oct;59(5):251–257. doi:10.1179/acb.2004.037
  • Iland HJ, Bradstock K, Supple SG, et al. Australasian Leukaemia and Lymphoma group. All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood. 2012 Aug 23;120(8):1570–1580. doi:10.1182/blood-2012-02-410746
  • Pizzo PA. Management of patients with fever and neutropenia through the Arc of time: a narrative review. Ann Intern Med. 2019 Mar 19;170(6):389–397. doi:10.7326/M18-3192
  • Yoshida I, Saito AM, Tanaka S, et al. Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever. Mycoses. 2020 Aug;63(8):794–801. doi:10.1111/myc.13100
  • Marr KA, Schlamm HT, Herbrecht R, et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. 2015 Jan 20;162(2):81–89. doi:10.7326/M13-2508
  • Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020 Sep 12;71(6):1367–1376. PMID: 31802125; PMCID: PMC7486838. doi:10.1093/cid/ciz1008
  • Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica. 2006 Jul;91(7):986–989. Epub 2006 Jun 1. PMID: 16757415.
  • Calus ST, Ijaz UZ, Pinto AJ. NanoAmpli-Seq: a workflow for amplicon sequencing for mixed microbial communities on the nanopore sequencing platform. Gigascience. 2018 Dec 1;7(12):giy140. PMID: 30476081. doi:10.1093/gigascience/giy140
  • Fujita SI, Senda Y, Nakaguchi S, et al. Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains. J Clin Microbiol. 2001 Oct;39(10):3617–3622. PMID: 11574582. doi:10.1128/JCM.39.10.3617-3622.2001
  • Kim BJ, Lee SH, Lyu MA, et al. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol. 1999 Jun;37(6):1714–1720. PMID: 10325313. doi:10.1128/JCM.37.6.1714-1720.1999
  • Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004 Sep 30;351(14):1391–1402. doi:10.1056/NEJMoa040446
  • Duarte RF, Sánchez-Ortega I, Cuesta I, et al. Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis. Clin Infect Dis. 2014 Dec 15;59(12):1696–1702. Epub 2014 Aug 27. PMID: 25165088. doi:10.1093/cid/ciu673
  • Teering S, Verreth A, Peeters A, et al. Prognostic value of serum galactomannan in mixed ICU patients: a retrospective observational study. Anaesthesiol Intensive Ther. 2014 Jul-Aug;46(3):145–154. PMID: 25078766. doi:10.5603/AIT.2014.0027
  • Russell JA, Campos B, Stone J, et al. Unbiased Strain-Typing of Arbovirus Directly from mosquitoes using nanopore sequencing: a field-forward biosurveillance protocol. Sci Rep. 2018 Apr 3;8(1):5417. PMID: 29615665. doi:10.1038/s41598-018-23641-7
  • Petersen LM, Martin IW, Moschetti WE, et al. Third-Generation sequencing in the clinical laboratory: exploring the advantages and challenges of nanopore sequencing. J Clin Microbiol. 2019 Dec 23;58(1):e01315–19. doi:10.1128/JCM.01315-19
  • van Dijk EL, Jaszczyszyn Y, Naquin D, et al. The third revolution in sequencing technology. Trends Genet. 2018 Sep;34(9):666–681. doi:10.1016/j.tig.2018.05.008
  • Russo A, Tiseo G, Falcone M, et al. Pulmonary aspergillosis: an evolving challenge for diagnosis and treatment. Infect Dis Ther. 2020 Sep;9(3):511–524. doi:10.1007/s40121-020-00315-4